INS3 Isogenic
STJUDEi004-A-1
General
Cell Line |
|
| hPSCreg name | STJUDEi004-A-1 |
| Cite as: | STJUDEi004-A-1 (RRID:CVCL_C6SU) |
| Alternative name(s) |
INS3 Isogenic
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
|
| Last update | 5th October 2022 |
| User feedback | |
Provider |
|
| Generator | St. Jude Children's Research Hospital (STJUDE) |
External Databases |
|
| BioSamples | SAMEA111437015 |
| Cellosaurus | CVCL_C6SU |
| Wikidata | Q117704899 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
| Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
| BioSamples | SAMEA111437014 |
Ethics
Also have a look at the ethics information for the parental line
STJUDEi004-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
STJUDEi004-A.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Medium |
mTeSR™ 1
|
Characterisation
No characterisation data could be found for this subclone. Please open parental cell line STJUDEi004-A .Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46, XX, normal human female
Karyotyping method:
G-Banding
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Disease/phenotype related modifications |
|

Login to share your feedback, experiences or results with the research community.